Cardiomyocyte‐enriched OTUD5 alleviates septic cardiomyopathy by promoting NLRP3 deubiquitination and inhibiting NLRP3 inflammasome activation
Abstract Background Septic cardiomyopathy (SCM) is the leading cause of mortality among patients diagnosed with sepsis. Nevertheless, the precise mechanisms underlying its pathogenesis remain poorly understood. Deubiquitinating enzymes (DUBs) play a vital role in various cardiovascular diseases. Met...
שמור ב:
| Principais autores: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2026-07-01
|
| סדרה: | Clinical and Translational Medicine |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/ctm2.70743 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
